At present, the publication of drug quality announcements not only varies from place to place, but also the “content” of drug quality announcements is quite different. In addition, since most of the drug quality announcements in various places were published on the official website of the Food and Drug Administration of the province (municipality, autonomous region) and not regularly published by the mass media, the audience’s attention was very limited, and the people were hardly ever more convenient and directly informed. way. According to industry sources, the openness of drug quality information is worrying, which has directly led to low public supervision of enterprises, hospitals, and pharmacies in some production and circulation sectors. The companies that have repeatedly been on the list have even gone wrong.

Poor punishment decision difficult to disclose

Through sorting out the 7-month drug quality announcements issued by the Jiangsu Province Food and Drug Administration in 2011 and 2012, the reporter asked how the pharmaceutical supervisory department selected the drug samples, and after the extracted drugs were tested as unqualified drugs. Whether there is any punishment for the sample supply unit has been questioned.

“Usually, it is not necessary to select which medicine produced by which manufacturer is used as a drug sample. However, there are usually two options: one is that a certain class of drug has a problem, such as a poison capsule event, or the past. There are certain drugs that are not qualified, we will increase the extraction of such drugs." Jiangsu Provincial Food and Drug Administration Inspection Bureau official told reporters.

"There is another kind of random selection. There is no regularity in this kind of basics, which is which one is drawn," said the person in charge.

When a reporter asked about whether the collected medicine was tested as a substandard medicine and whether the sample supply unit would be punished, the person in charge said that “the specific penalty is to be handled by the drug administration department of the district or county where the sample supply unit is located. It will certainly be punished. If it is not punished, it will be administrative inaction."

In the 7th issue of Jiangsu Province Drug Quality Bulletin, the Third People's Hospital of Jixian County was used as a sample supply unit and there were 3 issues in the list. "We were all punished at that time. The basis was the drug management law. We must have punished it." Shen County Chief of Food Inspection and Quarantine Inspection Team Shen told reporters.

Jiangsu Jiayi Pharmaceutical Co., Ltd., which is in the pharmaceutical sales process, has two periods of “listing” as a sample supply unit. “At that time, penalties imposed on our company were fines plus confiscation of illegal income. However, it was not a problem for us. It was a problem for manufacturers.” A female employee of the company’s quality department told the reporter.

A staff member of Quality Assurance Department of Kunshan Kyushu Tongda Pharmacy Chain Co., Ltd. is even more blunt. “The penalty is definitely a punishment, but it has no effect on us. Because the responsibility is not in us, we can directly find the manufacturer.”

Regarding whether or not you can see the penalty decision for these sample supply units, the person in charge of the Inspection Bureau of the Jiangsu Provincial Food and Drug Administration stated that this is not enough at present, and it is not necessary to look at it.

The masses are hard to learn about quality announcements

On the afternoon of March 26th, the reporter logged on to the website of the Jiangsu Provincial Food and Drug Administration. After reading the 7-month drug quality announcement, it was discovered that in the face of many ordinary people, the number of visits to these announcements can be described as pitifully. Among them, the most visited phase one was the third phase of 2012, which was released on February 6, 2013, with a total of 266 person-times. The minimum period was only 16 people.

"What is the drug quality announcement? I don't know, ah, I have never seen it before. I only saw on television what toxic capsules and poisons were exposed," said Uncle Liu, who bought medicine at the Wangwangxing pharmacy in Nanjing Dafang Lane.

An interview with the reporter found that not only people who do not have access to the Internet, such as the elderly, know about drug quality announcements, and some young people do not know. "I don't know where to see the drug quality announcement." A female university student who came to the Drum Tower Hospital was stunned. "Even if you see what's the use, do you know if all the unqualified drugs have been announced?" Counterfeit medicines are so hard to crack down. It is not exactly the same people who produce and sell them. Like waste oil, they all eat into the stomach of ordinary people."

“According to the provisions of the Drug Administration Law, drug regulatory departments at or above the provincial level have the right to issue drug quality announcements. However, there are no clear requirements on where to publish, and how many issues will be issued each year. Currently, the drug quality bulletin issued by the public has been released. We are publishing on our official website," the person in charge of the Jiangsu Provincial Food and Drug Administration Inspection Bureau told reporters.

Article 66 of the Drug Administration Law of the People's Republic of China stipulates that: The State Council and the drug regulatory agencies of the people's governments of provinces, autonomous regions, and municipalities directly under the Central Government shall regularly announce the results of random inspections of drug quality; if the announcement is improper, they must be corrected within the scope of the original announcement. . However, the reporter visited the official websites of several provincial and municipal food and drug administrations and found that the announcement of drug quality announcements in various provinces and municipalities was quite different, and most of them were in the form of announcements.

For example, the Chongqing Pharmaceutical Supervision Department issued two issues in 2012 and two issues in 2010. No relevant content was found in 2011. The newly released drug quality announcements that can be found in Liaoning, Anhui, Jilin, and Jiangxi are 2010, 2008, 2007, and 2005, respectively. Only the drug quality bulletin issued by Zhejiang Pharmaceutical Supervision Department is more detailed and the release cycle is more intensive. In recent years, more than four issues have been issued each year.

It should be noted that although the drug management law clearly stipulates, there are still some official websites of drug administration departments that can not find the drug quality announcement in the region at all, such as Shanghai, Hebei, Xinjiang, Yunnan, Jiangxi and other provinces. It is a national drug quality announcement issued by the State Food and Drug Administration. However, on the official website of the Shanxi Food and Drug Administration, no matter whether it is the province's drug quality announcement or the state's, the reporter could not find out.

A person from the legal profession in Jiangsu Province analyzed that many provincial drug regulatory agencies have made incomplete announcements or have not made public announcements. They are directly involved in administrative inaction and look forward to the newly established State Food and Drug Administration to pay attention and improve them in a timely manner. Otherwise, patients who buy drugs by mistake have the right to take up legal weapons to protect their rights. How to establish a transparent and open investigation mechanism for drug companies, hospitals and pharmacies to make and sell inferior drugs will directly affect the establishment of drug safety mechanisms.